Skip to main content

InMed Pharmaceuticals Inc.

INM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001728328

In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in InMed Pharmaceuticals Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
22
No complete 13F data for Q4 2020
Shares held
467.0K
No complete 13F data for Q4 2020
Total value
$1.55M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting INM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 22 institutions
Q1 2021: 22 institutionsQ2 2021: 20 institutionsQ3 2021: 19 institutionsQ4 2021: 18 institutionsQ1 2022: 19 institutionsQ2 2022: 18 institutionsQ3 2022: 15 institutionsQ4 2022: 14 institutionsQ1 2023: 15 institutionsQ2 2023: 10 institutionsQ3 2023: 10 institutionsQ4 2023: 17 institutionsQ1 2024: 18 institutionsQ2 2024: 14 institutionsQ3 2024: 15 institutionsQ4 2024: 5 institutionsQ1 2025: 5 institutionsQ2 2025: 7 institutionsQ3 2025: 9 institutionsQ4 2025: 7 institutionsQ1 2026: 9 institutionsQ2 2026: 20 institutions
Value heldQ1 2021: $1.55M
Q1 2021: $1.55MQ2 2021: $2.99MQ3 2021: $979.9KQ4 2021: $536.4KQ1 2022: $341.9KQ2 2022: $514.5KQ3 2022: $876.9KQ4 2022: $234.4KQ1 2023: $109.4KQ2 2023: $14.5KQ3 2023: $18.6KQ4 2023: $334.4KQ1 2024: $249.2KQ2 2024: $116.6KQ3 2024: $266.0KQ4 2024: $226.7KQ1 2025: $13.3KQ2 2025: $28.5KQ3 2025: $665.2KQ4 2025: $240.7KQ1 2026: $206.0KQ2 2026: $4.18M
Institutions holding INM and their total value by quarter
QuarterHoldersValue
Q2 202620$4.18M
Q1 20269$206.0K
Q4 20257$240.7K
Q3 20259$665.2K
Q2 20257$28.5K
Q1 20255$13.3K
Q4 20245$226.7K
Q3 202415$266.0K
Q2 202414$116.6K
Q1 202418$249.2K
Q4 202317$334.4K
Q3 202310$18.6K
Q2 202310$14.5K
Q1 202315$109.4K
Q4 202214$234.4K
Q3 202215$876.9K
Q2 202218$514.5K
Q1 202219$341.9K
Q4 202118$536.4K
Q3 202119$979.9K
Q2 202120$2.99M
Q1 202122$1.55M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding InMed Pharmaceuticals Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding INM in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC235,000$776.0K0.02%––
Hudson Bay Capital Management LP161,000$531.0K0.01%––
Citadel Advisors LLC17,211$57.0K0.00%––
Bank of America Corp16,120$53.0K0.00%––
Morgan Stanley12,581$41.0K0.00%––
JPMorgan Chase & Co7,472$36.0K0.00%––
Creative Planning10,990$36.0K0.00%––
The PNC Financial Services Group, Inc.1,820$6.00K0.00%––
Advisor Group Holdings, Inc.936$4.00K0.00%––
UBS Group AG793$3.00K0.00%––
Royal Bank of Canada586$2.00K0.00%––
Reilly Financial Advisors, LLC700$2.00K0.00%––
AllSquare Wealth Management LLC545$2.00K0.00%––
Bank of Montreal168$1.00K0.00%––
FourThought Financial, LLC424$1.00K0.00%––
Federation des caisses Desjardins du Quebec290$9620.00%––
HC Financial Advisors Inc24$00.00%––
TCI Wealth Advisors, Inc.125$00.00%––
Certified Advisory Corp30$00.00%––
Banque Cantonale Vaudoise3$00.00%––
Navigation Wealth Management, Inc.65$00.00%––
Better Money Decisions, LLC100$00.00%––